JFL Life

37
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LA901015
  • NSEID: JFLLIFE
  • BSEID:
INR
10.55
-0.4 (-3.65%)
BSENSE

Feb 04

BSE+NSE Vol: 24000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 76.25% vs 8.68% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 78.95% vs 16.67% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 25.71% vs -39.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 26.00% vs 17.47% in Mar 2024

Compare Profit and Loss Results of JFL Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
82.00
120.00
-38.00
-31.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
82.00
120.00
-38.00
-31.67%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-4.00
4.00
100.00%
Raw Materials Consumed
66.00
114.00
-48.00
-42.11%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
1.00
3.00
-2.00
-66.67%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
73.00
116.00
-43.00
-37.07%
Operating Profit (PBDIT) excl Other Income
8.00
4.00
4.00
100.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
8.00
6.00
2.00
33.33%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
7.00
3.00
4.00
133.33%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
6.00
2.00
4.00
200.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
2.00
4.00
200.00%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
4.00
2.00
2.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8.00
7.00
1.00
14.29%
Profit Available for appropriations
13.00
9.00
4.00
44.44%
Appropriations
13.00
9.00
4.00
44.44%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.26
2.57
-1.31
-50.97%
Profit And Loss - Net Sales
Net Sales 82.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 76.25% vs 8.68% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 78.95% vs 16.67% in Mar 2024

Profit And Loss - Interest
Interest 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.71% vs -39.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.00% vs 17.47% in Mar 2024